Menopausal Hot Flashes ' Pipeline Review, H2 2012

Please download to get full document.

View again

of 6
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Information Report
Category:

Slides

Published:

Views: 0 | Pages: 6

Extension: PDF | Download: 0

Share
Related documents
Description
Menopausal Hot Flashes ' Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Menopausal Hot Flashes - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes. Menopausal Hot Flashes - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Menopausal Hot Flashes.- A review of the Menopausal Hot Flashes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.- Coverage of the Menopausal Hot Flashes pipeline on the basis of route of administration and molecule type.- Key discontinued pipeline projects.- Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Menopausal Hot Flashes.- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.- Devise corrective measures for pipeline projects by understanding Menopausal Hot Flashes pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Transcript
  • 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Menopausal Hot Flashes Pipeline Review, H2 2012Published on September 2012 Report SummaryMenopausal Hot Flashes Pipeline Review, H2 2012SummaryGlobal Markets Directs, Menopausal Hot Flashes - Pipeline Review, H2 2012, provides an overview of the indications therapeuticpipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates,and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development forMenopausal Hot Flashes. Menopausal Hot Flashes - Pipeline Review, Half Year is built using data and information sourced fromGlobal Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured pressreleases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicateddisease.Scope- A snapshot of the global therapeutic scenario for Menopausal Hot Flashes.- A review of the Menopausal Hot Flashes products under development by companies and universities/research institutes based oninformation derived from company and industry-specific sources.- Coverage of products based on various stages of development ranging from discovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.- Coverage of the Menopausal Hot Flashes pipeline on the basis of route of administration and molecule type.- Key discontinued pipeline projects.- Latest news and deals relating to the products.Reasons to buy- Identify and understand important and diverse types of therapeutics under development for Menopausal Hot Flashes.- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitiveadvantage.- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.- Devise corrective measures for pipeline projects by understanding Menopausal Hot Flashes pipeline depth and focus of Indicationtherapeutics.- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects toenhance and expand business potential and scope.- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.Menopausal Hot Flashes Pipeline Review, H2 2012 (From Slideshare) Page 1/6
  • 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Table of ContentTable of ContentsTable of Contents 2List of Tables 4List of Figures 5Introduction 6Global Markets Direct Report Coverage 6Menopausal Hot Flashes Overview 7Therapeutics Development 8An Overview of Pipeline Products for Menopausal Hot Flashes 8Menopausal Hot Flashes Therapeutics under Development by Companies 10Menopausal Hot Flashes Therapeutics under Investigation by Universities/Institutes 11Late Stage Products 12Comparative Analysis 12Mid Clinical Stage Products 13Comparative Analysis 13Menopausal Hot Flashes Therapeutics Products under Development by Companies 14Menopausal Hot Flashes Therapeutics Products under Investigation by Universities/Institutes 15Companies Involved in Menopausal Hot Flashes Therapeutics Development 16Eisai Co., Ltd. 16Bionovo, Inc. 17PharmaNova Inc. 18Pherin Pharmaceuticals, Inc. 19Menopausal Hot Flashes Therapeutics Assessment 20Assessment by Monotherapy Products 20Assessment by Combination Products 21Assessment by Route of Administration 22Assessment by Molecule Type 24Drug Profiles 26gabapentin ER - Drug Profile 26Product Description 26Mechanism of Action 26R&D Progress 26gabapentin ER - Drug Profile 28Product Description 28Mechanism of Action 28R&D Progress 28RAD-1901 - Drug Profile 30Product Description 30Mechanism of Action 30R&D Progress 30liquiritigenin - Drug Profile 32Product Description 32Mechanism of Action 32R&D Progress 32Menopausal Hot Flashes Pipeline Review, H2 2012 (From Slideshare) Page 2/6
  • 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Acupuncture + Gabapentin - Drug Profile 34Product Description 34Mechanism of Action 34R&D Progress 34pregabalin - Drug Profile 35Product Description 35Mechanism of Action 35R&D Progress 35megestrol acetate - Drug Profile 36Product Description 36Mechanism of Action 36R&D Progress 36citalopram hydrobromide - Drug Profile 37Product Description 37Mechanism of Action 37R&D Progress 37progesterone - Drug Profile 38Product Description 38Mechanism of Action 38R&D Progress 38PH-80HF - Drug Profile 39Product Description 39Mechanism of Action 39R&D Progress 39gabapentin - Drug Profile 40Product Description 40Mechanism of Action 40R&D Progress 40Menopausal Hot Flashes Therapeutics Drug Profile Updates 41Menopausal Hot Flashes Therapeutics Discontinued Products 48Menopausal Hot Flashes Therapeutics - Dormant Products 49Menopausal Hot Flashes Product Development Milestones 50Featured News & Press Releases 50Aug 28, 2012: Eaton Scientific Announces Clinical Trial Plans For Tropine 3 For Treatment Of Hot Flashes In Menopausal Women 50Jul 31, 2012: Depomed Announces Submission Of Serada New Drug Application 50Apr 17, 2012: Depomed Intends To File NDA For Serada For Treatment Of Menopausal Hot Flashes 51Mar 28, 2012: Bionovos Independent Data Safety Monitoring Board Recommends Continuation Of Phase III Study For Menerba 51Nov 16, 2011: Bionovo To Begin Dosing In Menerba Phase III Clinical Trial For Menopausal Hot Flashes 52Oct 26, 2011: Bionovo Initiates Menerba Phase III Clinical Trial For Menopausal Hot Flashes 53Oct 13, 2011: Depomed Announces Top-Line Results From Serada Phase III Trial BREEZE 3 In Menopausal Hot Flashes 53Aug 30, 2011: Bionovo Announces Positive Results From Tolerability Trial Of Menerba For Menopausal Hot Flashes 54Jul 25, 2011: Bionovo Announces Successful Completion Of Animal Toxicology Studies For MF101 55Mar 28, 2011: Bionovo Initiates Enrollment In Menerba Phase I Tolerability Clinical Trial For Menopausal Hot Flushes 55Appendix 57Methodology 57Coverage 57Secondary Research 57Primary Research 57Menopausal Hot Flashes Pipeline Review, H2 2012 (From Slideshare) Page 3/6
  • 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Expert Panel Validation 57Contact Us 58Disclaimer 58List of TablesNumber of Products Under Development for Menopausal Hot Flashes, H2 2012 8Products under Development for Menopausal Hot Flashes Comparative Analysis, H2 2012 9Number of Products under Development by Companies, H2 2012 10Number of Products under Investigation by Universities/Institutes, H2 2012 11Comparative Analysis by Late Stage Development, H2 2012 12Comparative Analysis by Mid Clinical Stage Development, H2 2012 13Products under Development by Companies, H2 2012 14Products under Investigation by Universities/Institutes, H2 2012 15Eisai Co., Ltd., H2 2012 16Bionovo, Inc., H2 2012 17PharmaNova Inc., H2 2012 18Pherin Pharmaceuticals, Inc., H2 2012 19Assessment by Monotherapy Products, H2 2012 20Assessment by Combination Products, H2 2012 21Assessment by Stage and Route of Administration, H2 2012 23Assessment by Stage and Molecule Type, H2 2012 25Menopausal Hot Flashes Therapeutics Drug Profile Updates 41Menopausal Hot Flashes Therapeutics Discontinued Products 48Menopausal Hot Flashes Therapeutics Dormant Products 49List of FiguresNumber of Products under Development for Menopausal Hot Flashes, H2 2012 8Products under Development for Menopausal Hot Flashes Comparative Analysis, H2 2012 9Products under Development by Companies, H2 2012 10Products under Investigation by Universities/Institutes, H2 2012 11Late Stage Products, H2 2012 12Mid Clinical Stage Products, H2 2012 13Assessment by Monotherapy Products, H2 2012 20Assessment by Combination Products, H2 2012 21Assessment by Route of Administration, H2 2012 22Assessment by Stage and Route of Administration, H2 2012 23Assessment by Molecule Type, H2 2012 24Assessment by Stage and Molecule Type, H2 2012 25Menopausal Hot Flashes Pipeline Review, H2 2012 (From Slideshare) Page 4/6
  • 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Menopausal Hot Flashes Pipeline Review, H2 2012 Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 000.00 Quantity: _____ Site License--USD 4 000.00 Quantity: _____ Corporate License--USD 6 000.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Menopausal Hot Flashes Pipeline Review, H2 2012 (From Slideshare) Page 5/6
  • 6. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Menopausal Hot Flashes Pipeline Review, H2 2012 (From Slideshare) Page 6/6
  • We Need Your Support
    Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

    Thanks to everyone for your continued support.

    No, Thanks
    SAVE OUR EARTH

    We need your sign to support Project to invent "SMART AND CONTROLLABLE REFLECTIVE BALLOONS" to cover the Sun and Save Our Earth.

    More details...

    Sign Now!

    We are very appreciated for your Prompt Action!

    x